A Study of Drug-Induced Kidney Disease

August 1, 2008 updated by: National Taiwan University Hospital
The purpose of this study is to identify incidence of Chinese herb nephropathy in a medical center

Study Overview

Status

Unknown

Detailed Description

This is a retrospective study, by computer screening, chart review and phone survey to find herbal nephropathy and determine the cause-relationship.

Using ICD-9-CM code as a tool to screen the newly diagnosed ESRD in NTUH computer data base, and divided patients into those with underlying disease(s) that cause the renal failure and those without.

Study Type

Observational

Enrollment (Anticipated)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Fe-Lin L Wu, MSCP, Ph.D
  • Phone Number: 8389 886-2-23123456
  • Email: flwu@ntu.edu.tw

Study Contact Backup

  • Name: Kwan-Dun Wu, MD, Ph.D
  • Phone Number: 5014 886-2-23123456
  • Email: kdwu@ntuh.gov.tw

Study Locations

      • Taipei, Taiwan, 100
        • Recruiting
        • National Taiwan University Hospital
        • Contact:
          • Fe-Lin L. Wu, MSCP,Ph D
          • Phone Number: 8389 +886-2-23123456
          • Email: flwu@ntu.edu.tw
        • Contact:
          • Kwan-Dun Wu, MD, PhD
          • Phone Number: 5014 +886-2-23123456
          • Email: kdwu@ntuh.gov.tw
        • Principal Investigator:
          • Fe-Lin L. Wu, Ph D

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

a medical center

Description

Inclusion Criteria:

  • patient who was newly diagnosed as end stage renal disease who need dialysis

Exclusion Criteria:

  • started dialysis before 2000

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The incidence of herbal nephropathy
Time Frame: 5 years
5 years

Secondary Outcome Measures

Outcome Measure
Time Frame
The epidemiology of primary diagnosis for end stage renal disease in Taiwan
Time Frame: 5 years
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kwan-Dun Wu, MD, PhD, National Taiwan University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2008

Primary Completion (Anticipated)

September 1, 2008

Study Registration Dates

First Submitted

August 1, 2008

First Submitted That Met QC Criteria

August 1, 2008

First Posted (Estimate)

August 6, 2008

Study Record Updates

Last Update Posted (Estimate)

August 6, 2008

Last Update Submitted That Met QC Criteria

August 1, 2008

Last Verified

May 1, 2008

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on End Stage Renal Disease

3
Subscribe